The global spinal fusion device market size was valued at USD 6.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.4% from 2021 to 2028. Increasing numbers of spinal disorders and the growing geriatric population are boosting the market growth. According to the CDC report, around 34.0% of the adult population and 62.0% of the elderly population got affected by spinal deformities as of 2019. The common causes of spinal fusion injuries are found to be trauma, falls, collisions, or road traffic accidents.
The impact of the COVID-19 pandemic has been witnessed in nearly every industry. Like other healthcare markets, the market for spinal fusion devices has also been significantly affected. COVID-19 has led to postponed or deferred elective surgeries, a decline in sales, and dampened growth rate, among others. The decrease in surgical procedures drastically reduced the demand for devices and products required for spinal fusion. Although urgent and emergent surgeries were performed, there was a steep decline in the total number of procedures. Shortage of ICU beds and surgical rooms has been reported. Industry players witnessed slow growth and low net sales in the first two quarters of 2020.
After the initial impact of the pandemic, companies and governments started undertaking corrective actions to help the economy and businesses recover. These measures included policy and monetary stimuli, easing of restrictions, conditional exemptions, and other strategic initiatives. By Q3 2020, many companies reported recovery in sales with positive projections for the future. For instance, Stryker's spine segment revenue reported double-digit growth of 11.3% in 2021 Q1 as compared to 2020.
Pandemic Impact |
Post COVID Outlook |
The earlier projections depicting 4.0% YoY growth was countered by the pandemic resulting in the difference of USD ~22.6 million revenue in the earlier and recent estimations |
Gradual market recovery is anticipated from 2022 with a CAGR of over 4.5% (2022- 2028) owing to, resumption of elective surgeries, backlog, and increased target population |
|
Orthofix’s spinal implant revenue increased by 12% in q1 2021 from last year due to increased procedural volumes thus expected to boost the revenue in future |
|
|
The increasing adoption of minimally invasive surgeries (MIS) is further increasing the demand for spinal fusion devices. Surgeons are opting for MIS rather than open surgery owing to various advantages such as less pain, reduced post-operative duration, and less injury to the tissue. According to Mini-invasive Surgery in 2019, minimally invasive techniques are being adopted for the treatment of a wide range of bone disorders. Approximately 400,000 spinal fusion cases are performed in the U.S. annually and it has turned out to be one of the most commonly performed and well-established treatment options for spine trauma, degenerative disorders, and structural abnormalities.
The thoracolumbar devices segment dominated the market for spinal fusion devices and accounted for the largest revenue share of more than 55.0% in 2020. The increasing incidence of spinal disorders such as spinal stenosis, excessive kyphosis, and vertebral fracture is further driving the segment. In most of these cases, surgery is the only treatment option. Moreover, fractures in the thoracolumbar area can be the most important reason for surgical intervention. These fractures are either caused by road accidents or bone insufficiency. Bone insufficiency is caused for the reason of underlying settings such as osteoporosis and tumors that eventually weaken the bone and cause fractures.
The cervical segment is expected to grow fast in the market for spinal fusion devices over the forecast period owing to the rise in prevalence of cervical spondylosis in corporate professionals. Cervical spondylosis is a common disorder that is projected to account for 2% of all hospital admissions in the U.S. It is the most recurrent cause of spinal cord dysfunction in patients elder than 55 years. Based on radiologic findings, 90% of women elder than 60 years and 90% of men elder than 50 years have evidence of degenerative changes in the cervical spine, which is expected to support segment growth in the coming years.
The degenerative disc segment dominated the market for spinal fusion devices and accounted for the largest revenue share of over 42.0% in 2020. Growing reasons for lower back pain and neck pain in adults and an upsurge in elderly population are the major aspects driving the segment. In addition, rise in sports and daily activities is expected to augment segment growth.
The complex deformity segment is expected to grow fast in the market for spinal fusion devices over the forecast period. The demographics of the elderly population in the U.S. are experiencing a fundamental shift as medical care improvements and life expectancy increases. Moreover, the baby boomers represent the fastest rising demographic in the U.S. and the number of individuals 65 years and elder are projected to reach 89 million by 2050, more than double its existing size which is further boosting the revenue.
The minimally invasive surgery segment dominated the market for spinal fusion devices and accounted for the largest revenue share of 64.0% in 2020 as it’s the first preference for spinal fusion surgeries. According to a survey in 2019 in the U.S., the 3 most significant parameters for patients when selecting between MIS and open surgery were: surgeon's recommendation, complication risk, and long-term outcomes. When compared with MIS surgery, most patients experienced open surgery to be more painful, increased complication risk, increased recovery time, and need heavier sedation. Besides, if required to have spine surgery in the future, most of both patient groups would choose a minimally invasive approach. The aforementioned factors are expected to propel the revenue over the forecast period.
The hospitals dominated the market for spinal fusion devices and accounted for the largest revenue share of over 57.0% in 2020. The growing number of spinal surgeries performed at hospitals is one of the factors driving the segment. Growing government initiatives to improve the healthcare infrastructure and expanding the middle-class population in developing nations such as India are resulting in increasing demand for quality healthcare services delivered by hospitals, thereby aiding segment growth.
The specialty clinics segment is expected to grow fast in the market for spinal fusion devices over the forecast period. The popularity of these clinics is increasing over years. With the need for improved access to care, numerous types of specialty clinics have come to market over the last two decades. In addition, the increasing demand for better healthcare services has opened scope for new opportunities in delivering affordable healthcare services. Specialty clinics would mainly help in bridging the gap between the demand and supply of healthcare services and facilities by providing superior care. Hence, the aforementioned factors will support segment growth during the forecast period.
North America dominated the spinal fusion devices market and accounted for the largest revenue share of over 41.0% in 2020. The rising geriatric population, growing spinal disorder and increasing incidence of sports injuries and fatal accidents are among key factors boosting the demand for spinal fusion devices in North America. In addition, the presence of well-established healthcare infrastructure is expected to propel market growth in the region. Moreover, developments by key players are expected to boost market growth with huge untapped opportunities. In April 2019, Orthofix launched M6-C artificial cervical disc, the first commercial implant to increase its market penetration.
In Asia Pacific, the market for spinal fusion devices is expected to grow fast over the forecast period. The growth can be attributed to an increased number of medical tourism and government initiatives. Moreover, the growing target population in this region is further increasing the risk of spinal diseases and joint problems. In India, the market for spinal fusion devices is expected to show lucrative growth over the forecast period. The growth can be attributed to increased medical tourism in India for spinal fusion surgeries. There has been a 15 to 20% increase in the patient footfall in India for spinal fusion surgeries in the last 5 years, thus propelling demand.
The market for spinal fusion devices is highly competitive with many large and small industry players. These players are taking initiatives such as regional expansion, new product launches, partnerships, and collaborations to gain more market penetration. For instance, in November 2020 Aurora Spine Corporation launched the SOLO ALIF standalone cage system which will eventually decrease the surgery time. In January 2020, Medtronic acquired Stimgenics LLC to enhance its product portfolio. In July 2020, Zavation Medical Products introduced the Z-Span Expandable Anterior Lumbar Plate plates intended for use in the lumbar spine as additional fixation devices. Some of the prominent players in the spinal fusion device market include:
Johnson & Johnson Services, Inc. (DePuy Synthes)
Stryker
Zimmer Biomet
Orthofix Medical, Inc.
B. Braun Melsungen AG
Medtronic
NuVasive, Inc.
Globus Medical
ATEC Spine, Inc
Captiva Spine, Inc
SeaSpine
Spinal Elements, Inc.
Spine Wave, Inc.
Spineology, Inc.
Xtant Medical Holdings, Inc.
Report Attribute |
Details |
Market size value in 2021 |
USD 6.5 billion |
Revenue forecast in 2028 |
USD 8.8 billion |
Growth Rate |
CAGR of 4.4% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, disease type, surgery, end-user, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Japan; India; China; Brazil; Mexico; Argentina, South Africa; Saudi Arabia |
Key companies profiled |
Johnson & Johnson Services, Inc. (DePuy Synthes); Stryker; Zimmer Biomet; Orthofix Medical, Inc.; B. Braun Melsungen AG; Medtronic; NuVasive, Inc.; Globus Medical; ATEC Spine, Inc; Captiva Spine, Inc; SeaSpine; Spinal Elements, Inc.; Spine Wave, Inc.; Spineology, Inc.; Xtant Medical Holdings, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global spinal fusion device market report on the basis of product, disease type, surgery, end-user, and region:
Product Outlook (Revenue, USD Million, 2016 - 2028)
Thoracolumbar Devices
Anterior Lumbar Plates
Pedicle Screw and Rods
Others
Cervical Fixation Devices
Anterior Cervical Plates
Hook Fixation Systems
Others
Interbody Fusion Devices
Disease Type Outlook (Revenue, USD Million, 2016 - 2028)
Degenerative Disc
Complex Deformity
Trauma & Fractures
Others
Surgery Outlook (Revenue, USD Million, 2016 - 2028)
Open spine surgery
Minimally Invasive Spine Surgery
End-user Outlook (Revenue, USD Million, 2016 - 2028)
Hospitals
Specialty Clinics
Others
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
b. The degenerative disc segment dominated the spinal fusion device market and accounted for the largest revenue share of over 42.0% in 2020.
b. The minimally invasive surgery segment dominated the spinal fusion device market and accounted for the largest revenue share of 64.0% in 2020 as it’s the first preference for spinal fusion surgeries.
b. The hospitals dominated the spinal fusion device market and accounted for the largest revenue share of over 57.0% in 2020.
b. North America dominated the spinal fusion device market and accounted for the largest revenue share of over 41.0% in 2020.
b. The global spinal fusion device market size was estimated at USD 6.3 billion in 2020 and is expected to reach USD 6.5 billion in 2021.
b. The global spinal fusion device market is expected to grow at a compound annual growth rate of 4.4% from 2021 to 2028 to reach USD 8.8 billion by 2028.
b. The thoracolumbar devices segment dominated the spinal fusion device market and accounted for the largest revenue share of more than 55.0% in 2020.
b. Some of the prominent players in the spinal fusion device market include Johnson & Johnson Services, Inc. (DePuy Synthes), Stryker, Zimmer Biomet, Orthofix Medical, Inc., B. Braun Melsungen AG, Medtronic, NuVasive, Inc., Globus Medical, ATEC Spine, Inc, Captiva Spine, Inc, SeaSpine, Spinal Elements, Inc., Spine Wave, Inc.
b. Increasing numbers of spinal disorders and the growing geriatric population are boosting the market growth. The increasing adoption of minimally invasive surgeries (MIS) is further increasing the demand for the spinal fusion device market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."